Literature DB >> 29898008

The importance of the World Symposium on Pulmonary Hypertension.

Carlos Jardim1, Daniel Waetge2.   

Abstract

Entities:  

Year:  2018        PMID： 29898008      PMCID： PMC6188689          DOI： 10.1590/S1806-37562018000030001

Source DB:  PubMed          Journal:  J Bras Pneumol        ISSN： 1806-3713            Impact factor:   2.624


× No keyword cloud information.
  14 in total

1.  Bosentan therapy for pulmonary arterial hypertension.

Authors:  Lewis J Rubin; David B Badesch; Robyn J Barst; Nazzareno Galie; Carol M Black; Anne Keogh; Tomas Pulido; Adaani Frost; Sebastien Roux; Isabelle Leconte; Michael Landzberg; Gerald Simonneau
Journal:  N Engl J Med       Date:  2002-03-21       Impact factor: 91.245

Review 2.  Right heart adaptation to pulmonary arterial hypertension: physiology and pathobiology.

Authors:  Anton Vonk-Noordegraaf; François Haddad; Kelly M Chin; Paul R Forfia; Steven M Kawut; Joost Lumens; Robert Naeije; John Newman; Ronald J Oudiz; Steve Provencher; Adam Torbicki; Norbert F Voelkel; Paul M Hassoun
Journal:  J Am Coll Cardiol       Date:  2013-12-24       Impact factor: 24.094

3.  Effect of macitentan on hospitalizations: results from the SERAPHIN trial.

Authors:  Richard N Channick; Marion Delcroix; Hossein-Ardeschir Ghofrani; Elke Hunsche; Pavel Jansa; Franck-Olivier Le Brun; Sanjay Mehta; Tomás Pulido; Lewis J Rubin; B K S Sastry; Gérald Simonneau; Olivier Sitbon; Rogério Souza; Adam Torbicki; Nazzareno Galiè
Journal:  JACC Heart Fail       Date:  2014-11-11       Impact factor: 12.035

4.  Long-term response to calcium channel blockers in idiopathic pulmonary arterial hypertension.

Authors:  Olivier Sitbon; Marc Humbert; Xavier Jaïs; Vincent Ioos; Abdul M Hamid; Steeve Provencher; Gilles Garcia; Florence Parent; Philippe Hervé; Gérald Simonneau
Journal:  Circulation       Date:  2005-06-06       Impact factor: 29.690

5.  Pulmonary Arterial Hypertension-Related Morbidity Is Prognostic for Mortality.

Authors:  Vallerie V McLaughlin; Marius M Hoeper; Richard N Channick; Kelly M Chin; Marion Delcroix; Sean Gaine; Hossein-Ardeschir Ghofrani; Pavel Jansa; Irene M Lang; Sanjay Mehta; Tomás Pulido; B K S Sastry; Gérald Simonneau; Olivier Sitbon; Rogério Souza; Adam Torbicki; Victor F Tapson; Loïc Perchenet; Ralph Preiss; Pierre Verweij; Lewis J Rubin; Nazzareno Galiè
Journal:  J Am Coll Cardiol       Date:  2018-02-20       Impact factor: 24.094

6.  Acute vasodilator test in pulmonary arterial hypertension: evaluation of two response criteria.

Authors:  Eduardo Leite Vieira Costa; Carlos Jardim; Humberto Bassit Bogossian; Marcelo Britto Passos Amato; Carlos Roberto Ribeiro Carvalho; Rogerio Souza
Journal:  Vascul Pharmacol       Date:  2005-09       Impact factor: 5.773

Review 7.  A global view of pulmonary hypertension.

Authors:  Marius M Hoeper; Marc Humbert; Rogerio Souza; Majdy Idrees; Steven M Kawut; Karen Sliwa-Hahnle; Zhi-Cheng Jing; J Simon R Gibbs
Journal:  Lancet Respir Med       Date:  2016-03-12       Impact factor: 30.700

Review 8.  Cardiac magnetic resonance imaging: what can it add to our knowledge of the right ventricle in pulmonary arterial hypertension?

Authors:  Anton Vonk-Noordegraaf; Rogério Souza
Journal:  Am J Cardiol       Date:  2012-09-15       Impact factor: 2.778

9.  Aminorex and pulmonary hypertension. A review.

Authors:  H P Gurtner
Journal:  Cor Vasa       Date:  1985

10.  A comparison of continuous intravenous epoprostenol (prostacyclin) with conventional therapy for primary pulmonary hypertension.

Authors:  R J Barst; L J Rubin; W A Long; M D McGoon; S Rich; D B Badesch; B M Groves; V F Tapson; R C Bourge; B H Brundage; S K Koerner; D Langleben; C A Keller; S Murali; B F Uretsky; L M Clayton; M M Jöbsis; S D Blackburn; D Shortino; J W Crow
Journal:  N Engl J Med       Date:  1996-02-01       Impact factor: 91.245
View more
  1 in total

1.  Estimates of Prevalence of Pulmonary Hypertension according to Different International Definitions.

Authors:  Richa Tyagi; Surya Kant; Akshyaya Pradhan; Anupam Wakhlu; Darshan Kumar Bajaj; Jyoti Bajpai
Journal:  Can Respir J       Date:  2021-11-28       Impact factor: 2.409
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.